Eltromag 50 Tablet
Marketer
Cipla Ltd
Salt Composition
Eltrombopag (50mg)
Overview Eltromag 50 Tablet
Eltrombopag 50 mg tablets are indicated for managing low platelet counts stemming from chronic immune thrombocytopenic purpura (ITP) or chronic hepatitis C (HCV). This medication also addresses severe aplastic anemia. Acting as a thrombopoietin receptor agonist, eltrombopag boosts platelet production, thus improving hemostasis. Adhere strictly to your physician's prescribed dosage and regimen. Administration may be on an empty stomach; swallow the tablet whole – do not crush, chew, or break it. Report any allergies to this drug to your doctor. Commonly reported adverse effects include nausea, vomiting, diarrhea, upper respiratory infections, and urinary tract infections. Discuss any concerning side effects with your doctor; management strategies may be available. Prior to commencing treatment, disclose any pre-existing health issues and all concurrent medications. Dosage modifications might be necessary for patients with liver impairment; consult your doctor for guidance.
Uses of Eltromag 50 Tablet
Thrombocytopenia from immune thrombocytopenic purpura or hepatitis C; management of critical bone marrow failure
Major Benefits of Eltromag 50 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Eltromag 50 Tablet on an empty stomach.
Common Side effects of Eltromag 50 Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Eltromag 50 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; do not chew, crush, or fracture it. Administer Eltromag 50 Tablet on an empty stomach.
How Eltromag 50 Tablet works:
Eltrombopag 50 mg tablets act as a thrombopoietin receptor agonist, prompting increased platelet production in the bloodstream. This elevates platelet counts, thereby mitigating or averting hemorrhaging.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Eltromag 50 Tablet may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Eltromag 50 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Eltromag 50 Tablet while breastfeeding is likely inadvisable. Available data from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Eltromag 50 Tablet's side effects, including dizziness and reduced alertness. These effects can compromise safe driving.
KidneySAFE IF PRESCRIBED
Eltromag 50 Tablet can be used by patients with kidney disease without altering the dosage. Nevertheless, disclosure of kidney disease to your physician is necessary. Routine monitoring of kidney function is recommended during treatment with this medication.
LiverCAUTION
Patients with liver impairment should exercise caution when using Eltromag 50 Tablet, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Eltromag 50 Tablet :
Should you forget a dose of Eltromag 50 Tablet, omit that dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Eltromag 50 Tablet
| Label | Value |
|---|---|
| Chemical Type | Biphenyl Derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action class | Thrombopoietin receptor agonist |
3,018 People bought this recently